Urinary transferrin and proinflammatory markers predict the earliest diabetic nephropathy onset

References

• Ali, A., et al., 2019a. Effective dose of streptozotocin for induction of diabetes mellitus and associated mortality rate in Wistar albino rats. Pakistan Journal of Medicine and Dentistry, 8 (4), 50–54.
   Google Scholar
• Ali, A., et al., 2019b. Effects of diabetogenic agent streptozotocin on hematological parameters of Wistar albino rats “an experimental study”. Journal of Advances in Medicine and Medical Research, 6, 1–8.
   Google Scholar
• Alnek, K., et al., 2015. Increased blood levels of growth factors, proinflammatory cytokines, and Th17 cytokines in patients with newly diagnosed type 1 diabetes. PloS One, 10 (12), e0142976
   PubMed Web of Science ®Google Scholar
• American Diabetes Association, 2010. Diagnosis and classification of diabetes mellitus. Diabetes Care, 33 (Suppl 1), S62–S69.
   PubMed Web of Science ®Google Scholar
• Awad, A.S., et al., 2015. Macrophage-derived tumor necrosis factor-α mediates diabetic renal injury. Kidney International, 88 (4), 722–733.
   PubMed Web of Science ®Google Scholar
• Bakris, G.L., and Molitch, M., 2014. Microalbuminuria as a risk predictor in diabetes: the continuing saga. Diabetes Care, 37 (3), 867–875.
   PubMed Web of Science ®Google Scholar
• Besseling, P.J., et al., 2021. A plasma creatinine- and urea-based equation to estimate glomerular filtration rate in rats. American Journal of Physiology Renal physiology, 320 (3), F518–F524.
   PubMed Web of Science ®Google Scholar
• Burgos-Morón, E., et al., 2019. Relationship between oxidative stress, er stress, and inflammation in type 2 diabetes: the battle continues. Journal of Clinical Medicine, 8 (9), 1385.
   PubMed Web of Science ®Google Scholar
• Charlton, A., et al., 2021. Oxidative stress and inflammation in renal and cardiovascular complications of diabetes. Biology, 10 (1), 18.
   Google Scholar
• Eleazu, C.O., Iroaganachi, M., and Eleazu, K.C., 2013. Ameliorative potentials of cocoyam (Colocasia esculenta L.) and unripe plantain (Musa paradisiaca L.) on the relative tissue weights of streptozotocin-induced diabetic rats. Journal of Diabetes Research, 2013 (160964), 1–8.
   Google Scholar
• Furman, B.L., 2015. Streptozotocin-induced diabetic models in mice and rats. Current protocols in Pharmacology, 70, 5.47.1–5.47.20.
   PubMedGoogle Scholar
• Gluhovschi, C., et al., 2016. Urinary biomarkers in the assessment of early diabetic nephropathy. Journal of Diabetes Research, 2016 (4626125), 1–13.
   Google Scholar
• Jiang, X., et al., 2018. Associations of urinary, glomerular, and tubular markers with the development of diabetic kidney disease in type 2 diabetes patients. Journal of Clinical Laboratory Analysis, 32 (1), e22191.
   Web of Science ®Google Scholar
• Khan, N.U., et al., 2020. Insights into predicting diabetic nephropathy using urinary biomarkers. Biochimica et Biophysica Acta Proteins and Proteomics, 1868 (10), 140475.
   PubMed Web of Science ®Google Scholar
• Kumar, A., et al., 2008. Anti-diabetic activity of Syzygium cumini and its isolated compound against streptozotocin-induced diabetic rats. Journal of Medicinal Plants Research, 2 (9), 246–249.
   Google Scholar
• Lin, X., et al., 2015. Urine interleukin-18 in prediction of acute kidney injury: a systemic review and meta-analysis. Journal of Nephrology, 28 (1), 7–16.
   PubMed Web of Science ®Google Scholar
• Mise, K., et al., 2016. Prognostic value of tubulointerstitial lesions, urinary N-acetyl-β-d-glucosaminidase, and urinary β2-microglobulin in patients with type 2 diabetes and biopsy-proven diabetic nephropathy. Clinical Journal of the American Society of Nephrology, 11 (4), 593–601.
   PubMed Web of Science ®Google Scholar
• Mostafavinia, A., et al., 2016. The effects of dosage and the routes of administrations of streptozotocin and alloxan on induction rate of type1 diabetes mellitus and mortality rate in rats. Laboratory Animal Research, 32 (3), 160–165.
   PubMedGoogle Scholar
• Muller, Y.D., et al., 2011. Immunosuppressive effects of streptozotocin-induced diabetes result in absolute lymphopenia and a relative increase of T regulatory cells. Diabetes, 60 (9), 2331–2340.
   PubMed Web of Science ®Google Scholar
• Narita, T., et al., 2004. Parallel increase in urinary excretion rates of immunoglobulin G, ceruloplasmin, transferrin, and orosomucoid in normoalbuminuric type 2 diabetic patients. Diabetes care, 27 (5), 1176–1181.
   PubMed Web of Science ®Google Scholar
• Otsuka, Y., et al., 2012. A recurrent fibronectin glomerulopathy in a renal transplant patient: a case report. Clinical Transplantation, 26 Suppl 24 (Suppl 24), 58–63.
   PubMedGoogle Scholar
• Phosat, C., et al., 2017. Elevated C-reactive protein, interleukin 6, tumor necrosis factor alpha and glycemic load associated with type 2 diabetes mellitus in rural Thais: a cross-sectional study. BMC Endocrine Disorders, 2017; 17 (1), 44.
   Google Scholar
• Prinsen, B., et al., 2001. Transferrin synthesis is increased in nephrotic patients insufficiently to replace urinary losses. Journal of the American Society of Nephrology, 12 (5), 1017–1025.
   PubMed Web of Science ®Google Scholar
• Scurt, F.G., ROADMAP Steering Committee., et al., 2019. Systemic inflammation precedes microalbuminuria in diabetes. Kidney International Reports, 4 (10), 1373–1386.
   PubMed Web of Science ®Google Scholar
• Siddiqui, K., et al., 2020. Potential role and excretion level of urinary transferrin, KIM-1, RBP, MCP-1 and NGAL markers in diabetic nephropathy. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 13, 5103–5111.
   PubMed Web of Science ®Google Scholar
• Tesch, G.H. and Nikolic-Paterson, D.J., 2006. Recent insights into experimental mouse models of diabetic nephropathy. Nephron Experimental nephrology, 104 (2), e57–e62.
   PubMedGoogle Scholar
• Uwaezuoke, S.N., 2017. The role of novel biomarkers in predicting diabetic nephropathy: a review. International Journal of Nephrology and Renovascular Disease, 10, 221–231.
   PubMed Web of Science ®Google Scholar
• Wang-Fischer, Y. and Garyantes, T., 2018. Improving the reliability and utility of streptozotocin-induced rat diabetic model. Journal of Diabetes Research, 2018, 8054073.
   PubMed Web of Science ®Google Scholar
• Watts, A.K., Dwyer, K., Ekinci, E., Jerums, G., and Macisaac, R., 2015. The shifting paradigm of albuminuria in diabetic kidney disease. Neutral Bay: Medicine Today, 16 (7), 34–38.
   Google Scholar
• Xiao, L., et al., 2018. Oxidative DNA damage mediates the association between urinary metals and prevalence of type 2 diabetes mellitus in Chinese adults. Science of the Total Environment, 627, 1327–1333.
   PubMed Web of Science ®Google Scholar
• Zafar, M. and Naeem-Ul-Hassan Naqvi, S., 2010. Effects of STZ-induced diabetes on the relative weights of kidney, liver and pancreas in albino rats: a comparative study. International Journal of Morphology, 28 (1), 135–142.
   Web of Science ®Google Scholar
• Zheng, Z. and Zheng, F., 2016. Immune cells and inflammation in diabetic nephropathy. J. Dia. Res, 2016, 1841690.
   PubMed Web of Science ®Google Scholar